Market Forecast By Origin (Human Primary Cells, Animal Primary Cells), By Type (Hematopoietic Cells, Dermatocytes, Gastrointestinal Cells, Hepatocytes, Lung Cells, Renal Cells, Heart Cells, Musculoskeletal Cells), By End User (Life Science Research Companies, Research Institutes) And Competitive Landscape
Product Code: ETC269123 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
South Korea Primary Cells Market report thoroughly covers the market by Origin, Type, and End User. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help stakeholders devise and align their market strategies according to the current and future market dynamics.
South Korea primary cells market is experiencing notable growth and is projected to maintain this upward trajectory in the foreseeable future. This growth is largely driven by the expanding life sciences research sector, supported by substantial government investments in biotechnology and healthcare research.
According to 6Wresearch, South Korea primary cells market is projected to grow at a CAGR of 6.8% during the forecast period of 2025-2031. A major driving force behind this growth is the increasing use of primary cells in drug discovery and cancer research, propelled by the rising incidence of chronic diseases. Moreover, advancements in cell culture technology and the development of innovative cell-based assays are contributing significantly to market expansion.
However, challenges such as high costs associated with primary cell culture and the complexity of cell isolation and maintenance could impede market growth. Additionally, regulatory hurdles and ethical concerns related to the use of animal and human primary cells present further challenges.
Some of the key players in the South Korea primary cells market include Lonza Group Ltd., Thermo Fisher Scientific Inc., and Merck KGaA. These companies hold a significant market share due to their extensive product portfolios and robust distribution networks. Lonza Group Ltd., a Swiss multinational, is renowned for its comprehensive range of primary cells and cell culture media, catering to various research applications. Thermo Fisher Scientific Inc., an American multinational, offers a wide array of primary cells and related products, backed by strong research and development capabilities. Merck KGaA, a German multinational, is also a prominent player, providing advanced primary cell solutions for diverse life science research applications.
The South Korean government has initiated several programs to bolster the biotechnology and healthcare sectors, driving the demand for primary cells. The government's Bioeconomy Strategy aims to position South Korea as a global leader in biotechnology by fostering innovation and investment in life sciences research. This strategy includes funding for research institutes and incentives for private sector investment, which are expected to boost the primary cells market. Additionally, regulatory frameworks have been established to ensure ethical standards in biomedical research, promoting the use of primary cells in a responsible manner. The government's support for precision medicine and personalized healthcare further stimulates the demand for high-quality primary cells.
The South Korea primary cells market is poised for significant growth in the coming years, driven by factors such as increased research activities in genomics and personalized medicine, and the development of advanced cell culture technologies. The nation's goal to become a leading biotechnology hub by 2030 will further propel market growth. Moreover, with a strong focus on reducing healthcare costs and improving treatment outcomes, there is a growing trend towards using primary cells in regenerative medicine and tissue engineering.
Technological advancements, such as the development of 3D cell culture models and automated cell culture systems, are expected to further accelerate market growth. Overall, the South Korea primary cells market holds promising growth potential, with a focus on innovative and sustainable research solutions.
According to Ravi Bhandari, Research Head, 6Wresearch, human primary cells are currently leading the market. This is attributed to their extensive use in medical research and drug development.
Hematopoietic cells are the most widely used in South Korea, driven by their crucial role in cancer and immunology research. The demand for these cells is expected to continue rising with advancements in cancer treatments and regenerative medicine.
Life science research companies are the primary consumers of primary cells in South Korea. These companies leverage primary cells for various applications, including drug discovery, toxicology studies, and tissue engineering.
The report provides a detailed analysis of the following market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Primary Cells Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Primary Cells Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Primary Cells Market - Industry Life Cycle |
3.4 South Korea Primary Cells Market - Porter's Five Forces |
3.5 South Korea Primary Cells Market Revenues & Volume Share, By Origin, 2021 & 2031F |
3.6 South Korea Primary Cells Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 South Korea Primary Cells Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Korea Primary Cells Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and regenerative therapies |
4.2.2 Growing investments in research and development activities in the biopharmaceutical sector |
4.2.3 Rise in prevalence of chronic diseases leading to higher demand for primary cells |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for cell-based therapies in South Korea |
4.3.2 High cost associated with primary cell isolation and culture processes |
5 South Korea Primary Cells Market Trends |
6 South Korea Primary Cells Market, By Types |
6.1 South Korea Primary Cells Market, By Origin |
6.1.1 Overview and Analysis |
6.1.2 South Korea Primary Cells Market Revenues & Volume, By Origin, 2021-2031F |
6.1.3 South Korea Primary Cells Market Revenues & Volume, By Human Primary Cells, 2021-2031F |
6.1.4 South Korea Primary Cells Market Revenues & Volume, By Animal Primary Cells, 2021-2031F |
6.2 South Korea Primary Cells Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 South Korea Primary Cells Market Revenues & Volume, By Hematopoietic Cells, 2021-2031F |
6.2.3 South Korea Primary Cells Market Revenues & Volume, By Dermatocytes, 2021-2031F |
6.2.4 South Korea Primary Cells Market Revenues & Volume, By Gastrointestinal Cells, 2021-2031F |
6.2.5 South Korea Primary Cells Market Revenues & Volume, By Hepatocytes, 2021-2031F |
6.2.6 South Korea Primary Cells Market Revenues & Volume, By Lung Cells, 2021-2031F |
6.2.7 South Korea Primary Cells Market Revenues & Volume, By Renal Cells, 2021-2031F |
6.2.8 South Korea Primary Cells Market Revenues & Volume, By Musculoskeletal Cells, 2021-2031F |
6.2.9 South Korea Primary Cells Market Revenues & Volume, By Musculoskeletal Cells, 2021-2031F |
6.3 South Korea Primary Cells Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 South Korea Primary Cells Market Revenues & Volume, By Life Science Research Companies, 2021-2031F |
6.3.3 South Korea Primary Cells Market Revenues & Volume, By Research Institutes, 2021-2031F |
7 South Korea Primary Cells Market Import-Export Trade Statistics |
7.1 South Korea Primary Cells Market Export to Major Countries |
7.2 South Korea Primary Cells Market Imports from Major Countries |
8 South Korea Primary Cells Market Key Performance Indicators |
8.1 Average time taken for primary cell isolation and culture |
8.2 Number of partnerships and collaborations between research institutions and biopharmaceutical companies in South Korea |
8.3 Percentage of research funding allocated to primary cell research in the country |
9 South Korea Primary Cells Market - Opportunity Assessment |
9.1 South Korea Primary Cells Market Opportunity Assessment, By Origin, 2021 & 2031F |
9.2 South Korea Primary Cells Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 South Korea Primary Cells Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Korea Primary Cells Market - Competitive Landscape |
10.1 South Korea Primary Cells Market Revenue Share, By Companies, 2024 |
10.2 South Korea Primary Cells Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |